MAPT and Alzheimer disease: Moreover, a good accuracy of blood t-tau in predicting the tau-PET status among CU, MCI, and AD patients is reported, while this biomarker could poorly discriminate amyloid-positive from negative participants in analogous clinical populations [32,33].